These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31390940)

  • 1. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
    Máiz Carro L; Martínez-García MA
    Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patients.
    Máiz L; Girón RM; Prats E; Clemente MG; Polverino E; Caño S; Cordovilla R; Dorca J; Peñalver C; Baranda F; Martínez-García MA
    Ther Adv Respir Dis; 2018; 12():1753466618787385. PubMed ID: 30014774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M; Casciaro R; Lucca F; Troiani P; Salonini E; Favilli F; Quattrucci S; Sher D; Assael BM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
    Anuradha KWDA; Gunathilaka PKG; Wickramasinghe VP
    Pediatr Pulmonol; 2021 Feb; 56(2):509-515. PubMed ID: 33295693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial.
    Herrero-Cortina B; Alcaraz V; Vilaró J; Torres A; Polverino E
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):281-289. PubMed ID: 29878856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].
    Máiz Carro L; Lamas Ferreiro A; Ruiz de Valbuena Maiz M; Wagner Struwing C; Gabilondo Álvarez G; Suárez Cortina L
    Med Clin (Barc); 2012 Feb; 138(2):57-9. PubMed ID: 21511313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
    Koskela H; Purokivi M
    Duodecim; 2011; 127(24):2653-9. PubMed ID: 22320108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.
    Buonpensiero P; De Gregorio F; Sepe A; Di Pasqua A; Ferri P; Siano M; Terlizzi V; Raia V
    Adv Ther; 2010 Nov; 27(11):870-8. PubMed ID: 20953746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Main E; Grillo L; Rand S
    Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.
    Rosenfeld M; Davis S; Brumback L; Daniel S; Rowbotham R; Johnson R; McNamara S; Jensen R; Barlow C; Ratjen F
    Pediatr Pulmonol; 2011 Jul; 46(7):666-71. PubMed ID: 21365779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled mucoactive drugs for treating non-cystic fibrosis bronchiectasis in children.
    Snijders D; Calgaro S; Bertozzi I; Quartesan S; Kozuh I; Lunardi F; Barbato A
    Int J Immunopathol Pharmacol; 2013; 26(2):529-34. PubMed ID: 23755770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.